http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4068003-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8f4c2477bdea308bc9dec3feded37457
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-12
filingDate 1977-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1978-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcbdf458488a4401d8f6a2b2a43b733e
publicationDate 1978-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-4068003-A
titleOfInvention Method of medical treatment of myasthenia
abstract The invention relates to a new use of Coenzyme Q compounds, and more particularly, to a method of medical treatment of myasthenia by administering Coenzyme Q compounds.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03077951-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004066988-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006073131-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6461593-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1588703-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004156836-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005209343-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0208833-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1588703-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4491594-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0118132-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0118132-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7033588-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8946303-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0208833-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4824669-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4525350-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006165672-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7708990-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5011858-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4885167-A
priorityDate 1976-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3313781-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3531437-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-3421625-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280473
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7270
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID103023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449071750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454582909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136169097
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575416
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394131
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226514466
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136035395
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10953859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226628643
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419475261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID161837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27522
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2131

Total number of triples: 61.